Since most of our patients with MS continue to be symptomatic despite the use of immunomodulating agents, it is important for the treating neurologist to be familiar with treatments for these symptoms, many of which are extremely disabling to the patient. Knowing how to deal with common ...
Moreover, symptoms in people with multiple sclerosis differ from person to person. Visual, sensory, and motor signs and symptoms are all part of MS; however, there is a wide range of symptoms that can appear. Some people have mild cases of MS with little or no disability over the years....
Multiple sclerosis (MS) is a chronic, often disabling disease that affects the central nervous system. Symptoms of multiple sclerosis may be mild, such
About 350,000 persons in the United States have multiple sclerosis, and primary care physicians are often called on to provide symptomatic therapy for these patients. We review our current pharmacologic approach to the management of multiple sclerosis exacerbations and the symptoms of spasticity, fatigu...
Symptoms, causes, and treatments for MS in children and teens are similar to those for adults, except children and teens may also have seizures and/or mental status changes. Multiple sclerosis symptoms and signs depend on where the nerves are demyelinated and may include: Visual changes inclu...
netic resonance imaging characteristic of multiple sclerosis (clinically isolated syndrome) to see if outcomes would be better if therapy was started when Types of multiple sclerosis symptoms first arose and the patient had not had a About 85% of patients with multiple sclerosis present second ...
While multiple sclerosis symptoms like pain, spasticity, and muscle weakness can significantly impact mobility, there are many ways to successfully manage these challenges over time. In fact, many of Ottobock’s NeuroMobility solutions are specifically designed to support and protect mobility for those...
Further research will explore the optimal conditions for clinical application and potential development of even more effective treatments. Source: Cincinnati Children’s Hospital When treated with a novel protein function inhibitor called ESI1, mice that mimic the symptoms of multiple sclerosis (MS) and...
The incidence of flu-like symptoms is ∼50% for interferon-β1a55, 56 and ∼75% for interferon-β1b.57 Gradual titration of dose over the first 3–4 weeks of therapy, premedicating with acetaminophen or nonsteroidal anti-inflammatories, and giving the injection at bedtime are strategies...
Figure 2. Neurologist medical record documentation of multiple sclerosis (MS) symptoms at presentation (A) and during historical period (B) in a medical record study sample of disease-modifying therapy users (n = 327). Imaging and Evaluation of MS Severity MRI was the most frequently used imagi...